Cargando…
High-resolution melting analysis coupled with next-generation sequencing as a simple tool for the identification of a novel somatic BRCA2 variant: a case report
In a 72-year-old woman with no associated personal or family history of breast and/or ovarian cancers, we identified a novel somatic pathogenic BRCA2 variant (c.18_28delAGAGAGGCCAA, p.Lys6Asnfs*4) using next-generation sequencing (NGS). The variant allele frequency (VAF) was 16%, and Sanger sequenci...
Autores principales: | Costella, Alessandra, De Leo, Rossella, Guarino, Donatella, D’Indinosante, Marco, Concolino, Paola, Mazzuccato, Giorgia, Urbani, Andrea, Scambia, Giovanni, Capoluongo, Ettore, Fagotti, Anna, Minucci, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993729/ https://www.ncbi.nlm.nih.gov/pubmed/29899995 http://dx.doi.org/10.1038/s41439-018-0006-x |
Ejemplares similares
-
BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants
por: Concolino, Paola, et al.
Publicado: (2019) -
Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome
por: Minucci, Angelo, et al.
Publicado: (2018) -
BRCA testing delay during the COVID-19 pandemic: How to act?
por: Minucci, Angelo, et al.
Publicado: (2020) -
NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer
por: Marchetti, Claudia, et al.
Publicado: (2021) -
A commentary on the discrepancy between blood and tumour
BRCA
testing: An open question
por: De Paolis, Elisa, et al.
Publicado: (2022)